WE DO NOT SHIP TO RESIDENTIAL ADDRESSES. For pricing in CAD/AUD/NZD please contact us.

Recombinant Rat Insulinlike growth factor I (rRtIGF-1) - PR3006

Recombinant Rat Insulinlike growth factor I (rRtIGF-1) - PR3006

Regular price
$0.00
Regular price
Sale price
$0.00
Unit price
per 
Availability
Sold out

Recombinant Rat Insulinlike growth factor I (rRtIGF-1)

Catalogue Numbers: PR3006-10, PR3006-50

Sizes: 10µg, 50µg

Source: Escherichia coli

Molecular Weight: Approximately 7.7 kDa, a single non-glycosylated polypeptide chain containing 70 amino acid residues.

Purity: >97% by SDS-PAGE and HPLC analyses.

Biological Activity: Measured in a serum free cell proliferation assay using MCF7 human breast adenocarcinoma cells.
The ED50 for this effect is typically 0.6-3 ng/mL.

Physical Appearance: Sterile Filtered White lyophilized (freeze-dried) powder.

Formulation: Lyophilized from a 0.2mm filtered concentrated solution in PBS, pH 7.4.

AA Sequence: GPETLCGAEL VDALQFVCGP RGFYFNKPTG YGSSIRRAPQ TGIVDECCFR SCDLRRLEMY CAPLKPTKSA

Endotoxin: Less than 1EU/μg of rRtIGF-1 as determined by LAL method.

Reconstitution: We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at <-20°C. Further dilutions should be made in appropriate buffered solutions.

Storage: This lyophilized preparation is stable at 2-8°C, but should be kept at -20°C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8°C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20°C to -70°C. Avoid repeated freeze/thaw cycles.

Usage: This material is offered by USA Bioworld biotech for research, laboratory or further evaluation purposes. NOT FOR HUMAN USE. Made in China

Description: Insulinlike growth factor I, also known as somatomedin C, is the dominant effector of growth hormone and is structurally homologous to proinsulin. It shares 61% aa sequence identity with mature rat IGF-II. Circulating IGF-I is produced by hepatocytes, while local IGF-I is produced by many other tissues in which it has paracrine effects. IGF-I induces the proliferation, migration, and differentiation of a wide variety of cell types during development and postnatally.